BIBLIOGRAPHIE AINAT
(1) Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. Br Med J 2004; 329:15-9
(2) Bardin T, Lemaire V, Berenbaum F. Anti-inflammatoires non stéroïdiens et cœur. Actualités Rhumatologiques 2006 Elsevier pp : 433-444
(3) Wolfe MM,
N Engl J Med 1999; 340:1888-99.
(4) THIEFIN G. Complications gastro-intestinales des anti-inflammatoires non stéroïdiens et de l'aspirine à faible dose. Gastroentérol. clin. biol. 2003, vol. 27, no5, pp. 498-510
(5) Flipo RM, Bertin P. Connaissance par les médecins et les patients du risque de complications digestives des AINS. Presse Med 2003 ; 32 : 4S48-4S52
(6) Valat JP. AINS et complications cardiovasculaires et rénales.
(7) Sibilia J, Deray G, Montalescot G. Que connaît-on de la toxicité cardiovasculaire des AINS ?
(8) Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non steroidal antiinflammatory drugs nested case-control study.
Lancet 2005; 365:475-81.
(9) Flipo RM, HéloireF, Deray G. Quelles informations délivrer au patient sur le risque cardiovasculaire et rénal des AINS ?
(10) http://afssaps.sante.fr/htm/5/rbp/indrbp.htm (rubrique : « documents et publications, autres documents, RMO, prescription des anti-inflammatoires non séroïdiens »)
HARPAGOPHYTUM :
Moussard C, Alber D, et al. A drug used in traditional medicine, harpagophytum procumbens: no evidence for NSAID-like effect on whole blood eicosanoid production in human.Prostaglandins Leukot Essent Fatty Acids 1992 Aug;46(4):283-6.
Loew D, Mollerfeld J, et al. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo.Clin Pharmacol Ther 2001 May;69(5):356-64.
Chantre P, Cappelaere A, et al. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine. 2000 Jun;7(3):177-83.
Chrubasik S, Model A, et al. A randomized double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low back pain.Rheumatology (
Wegener T. Degenerative diseases of the musculoskeletal system--overview of current clinical studies of Devil's Claw (Harpagophyti radix). Wien Med Wochenschr 2002;152(15-16):389-92.
Chrubasik S, Thanner J, et al. Comparison of outcome measures during treatment with the proprietary Harpagophytum extract doloteffin in patients with pain in the lower back, knee or hip.Phytomedicine 2002 Apr;9(3):181-94.
Gagnier JJ, Chrubasik S, Manheimer E. Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review. BMC Complement Altern Med. 2004 Sep 15;4:13.
Wegener T, Lupke NP. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC.). Phytother Res. 2003 Dec;17(10):1165-72.
Chrubasik S, Junck H, et al. Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomized, placebo-controlled, double-blind study.Eur J Anaesthesiol 1999 Feb;16(2):118-29.
BROMELAÏNE :
Kelly GS. Bromelain: A Literature Review and Discussion of its Therapeutic Applications.Alt Med Rev 1996;1(4):243-257.
MacKay D, Miller AL. Nutritional support for wound healing. Altern Med Rev. 2003 Nov;8(4):359-77.
Cirelli MG. Five years of clinical experience with bromelains in therapy of edema and inflammation in postoperative tissue reaction, skin infections and trauma. Clinical Medicine 1967;74(6):55-59.
Kamenicek V, Holan P, Franek P. Systemic enzyme therapy in the treatment and prevention of post-traumatic and postoperative swelling. Acta Chir Orthop Traumatol Cech. 2001;68(1):45-9. Czech.
Klein G, Kullich W, et al. Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol. 2006 Jan-Feb;24(1):25-30.
Akhtar NM, Naseer R, et al. Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee--a double-blind prospective randomized study. Clin Rheumatol. 2004 Oct;23(5):410-5.
Srimal RC et al. A preliminary report on anti-inflammatory activity of curcumin. Indian Journal of Pharmacology 1971 ;3:10
Satoskar RR, Shah SJ, Shenoy SG. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol 1986 Dec;24(12):651-4.
Kulkarni RR, Patki PS, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study.J Ethnopharmacol 1991 May-Jun;33(1-2):91-5.
Badmaev V, Majeed M. Curcuma and Curcuminoids. Natural Health Products Report 2000 March;9 (3):26-9
Badmaev V, Majeed M. A bioprotector from curcuma . Parfum cosmét. actual 2000 ;154 :48-49
Funk JL, Frye JB et al. Efficacy and mechanism of action of tumeric supplements in the treatment of experimental arthritis. Arthritis Rheum 2006 Oct 30;54(11):3452-3464
Srivastava R. Inhibition of neutrophil response by curcumin. Collect Secur 1989;28 (3-4):298-303
Nita Chainani-Wu. Safety and anti-inflammatry activity of curcumin: a component of tumeric (Curcuma longa).
The Journal of Alternative and Complementary Medicine. 2003, 9(1): 161-168 Ramsewak, R.S., DeWitt,
D.L., Nair, M.G. Cytotoxicity, antioxidant, and anti-inflammatory activities of Curcumins I-III from Curcuma longa. Phytomedicine 2000;7(4):303-308
Arora, R.B. Basu, N., Kapoor, V., Jain, A.P. Anti-inflammatory studies on Curcuma longa (Turmeric). Indian
J Med Res 1971;59(8):1289-95.
